drugset / Trial / NCT02706236

Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis

NCT02706236 ↗

RandomizedCrossoverDouble-blindTreatment

Summary

The study purpose is to characterize the effect of pancreatic enzyme supplementation on chronic pancreatitis type pain.

Timeline

Start
2016-04
Primary completion
2018-12
Completion
2018-12

Outcome

Outcome not reported

Stopped (Business): “no funding was awarded”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pancrelipase Protein / enzyme biologic 720000 iu Oral

Indications